Test Bank Pharmacology A Patient-
. . . .
. Centered Nursing Process Approach
. . .
10th Edition by McCuistion
. . . .
,CONTENTS
Section I: Introduction to Pharmacology
. . . .
1. The Nursing Process and Patient-Centered Care
. . . . .
2. Drug Development and Ethical Considerations
. . . .
3. Pharmacokinetics and Pharmacodynamics . .
4. Pharmacogenetics
5. Complementary and Alternative Therapies . . .
6. Pediatric Considerations .
7. Older Adult Considerations
. .
8. Drugs in Substance Use Disorder
. . . .
Section II: Pharmacotherapy and Drug Administration
. . . . .
9. Safety and Quality . .
10. Drug Administration .
11. Drug Calculations .
Section III: Maintenance of Homeostasis
. . . .
12. Fluid Volume and Electrolytes
. . .
13. Vitamin and Mineral Replacement . . .
14. Nutritional Support .
Section IV: Autonomic Nervous System Drugs
. . . . .
15. Adrenergic Agonists and Antagonists . . .
,16. Cholinergic Agonists and Antagonists . . .
Section V: Central and Peripheral Nervous System Drugs
. . . . . . .
17. Stimulants
18. Depressants
19. Antiseizure Drugs .
20. Drugs for Parkinsonism and Alzheimer’s Disease
. . . . .
21. Drugs for Neuromuscular Disorders and Muscle Spasms
. . . . . .
Section VI: Mental and Behavioral Health Drugs
. . . . . .
22. Antipsychotics and Anxiolytics . .
23. Antidepressants and Mood Stabilizers . . .
Section VII: Pain and Inflammation Management Drugs
. . . . . .
24. Antiinflammatories
25. Analgesics
Section VIII: Antimicrobial Drugs
. . .
26. Antibacterials
1. Section A: Penicillins and Cephalosporins
. . . .
2. Section B: Macrolides and Tetracyclines
. . . .
3. Section C: Aminoglycosides and Fluoroquinolones
. . . .
4. Section D: Sulfonamides and Metronidazole
. . . .
27. Antituberculars, Antifungals, and Antivirals . . .
28. Antimalarials, Anthelmintics, and Peptides . . .
, Section IX: Immunologic Drugs
. . .
29. HIV- and AIDS-Related Drugs
. . .
30. Transplant Drugs .
31. Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
. . . . . .
32. Anticancer Drugs .
33. Targeted Therapies to Treat Cancer
. . . .
34. Biologic Response Modifiers
. .
Section XI: Respiratory Drugs
. . .
35. Upper Respiratory Disorders
. .
36. Lower Respiratory Disorders
. .
Section XII: Cardiovascular Drugs
. . .
37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
. . . .
38. Diuretics
39. Antihypertensives
1. Section A: Beta Blockers
. . .
2. Section B: Alpha Blockers
. . .
3. Section C: Drugs Affecting RAAS
. . . .
4. Section D: Calcium Channel Blockers
. . . .
40. Anticoagulants, Antiplatelets, and Thrombolytics . . .
41. Antihyperlipidemics and Drugs to Improve Peripheral Blood . . . . . .
. . . .
. Centered Nursing Process Approach
. . .
10th Edition by McCuistion
. . . .
,CONTENTS
Section I: Introduction to Pharmacology
. . . .
1. The Nursing Process and Patient-Centered Care
. . . . .
2. Drug Development and Ethical Considerations
. . . .
3. Pharmacokinetics and Pharmacodynamics . .
4. Pharmacogenetics
5. Complementary and Alternative Therapies . . .
6. Pediatric Considerations .
7. Older Adult Considerations
. .
8. Drugs in Substance Use Disorder
. . . .
Section II: Pharmacotherapy and Drug Administration
. . . . .
9. Safety and Quality . .
10. Drug Administration .
11. Drug Calculations .
Section III: Maintenance of Homeostasis
. . . .
12. Fluid Volume and Electrolytes
. . .
13. Vitamin and Mineral Replacement . . .
14. Nutritional Support .
Section IV: Autonomic Nervous System Drugs
. . . . .
15. Adrenergic Agonists and Antagonists . . .
,16. Cholinergic Agonists and Antagonists . . .
Section V: Central and Peripheral Nervous System Drugs
. . . . . . .
17. Stimulants
18. Depressants
19. Antiseizure Drugs .
20. Drugs for Parkinsonism and Alzheimer’s Disease
. . . . .
21. Drugs for Neuromuscular Disorders and Muscle Spasms
. . . . . .
Section VI: Mental and Behavioral Health Drugs
. . . . . .
22. Antipsychotics and Anxiolytics . .
23. Antidepressants and Mood Stabilizers . . .
Section VII: Pain and Inflammation Management Drugs
. . . . . .
24. Antiinflammatories
25. Analgesics
Section VIII: Antimicrobial Drugs
. . .
26. Antibacterials
1. Section A: Penicillins and Cephalosporins
. . . .
2. Section B: Macrolides and Tetracyclines
. . . .
3. Section C: Aminoglycosides and Fluoroquinolones
. . . .
4. Section D: Sulfonamides and Metronidazole
. . . .
27. Antituberculars, Antifungals, and Antivirals . . .
28. Antimalarials, Anthelmintics, and Peptides . . .
, Section IX: Immunologic Drugs
. . .
29. HIV- and AIDS-Related Drugs
. . .
30. Transplant Drugs .
31. Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
. . . . . .
32. Anticancer Drugs .
33. Targeted Therapies to Treat Cancer
. . . .
34. Biologic Response Modifiers
. .
Section XI: Respiratory Drugs
. . .
35. Upper Respiratory Disorders
. .
36. Lower Respiratory Disorders
. .
Section XII: Cardiovascular Drugs
. . .
37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
. . . .
38. Diuretics
39. Antihypertensives
1. Section A: Beta Blockers
. . .
2. Section B: Alpha Blockers
. . .
3. Section C: Drugs Affecting RAAS
. . . .
4. Section D: Calcium Channel Blockers
. . . .
40. Anticoagulants, Antiplatelets, and Thrombolytics . . .
41. Antihyperlipidemics and Drugs to Improve Peripheral Blood . . . . . .
